Resumen de acción CLPT
ClearPoint Neuro, Inc. opera como empresa de dispositivos médicos principalmente en Estados Unidos.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Competidores de ClearPoint Neuro, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$5.33 |
| 52 Week High | US$10.57 |
| 52 Week Low | US$4.05 |
| Beta | 0.92 |
| 1 Month Change | -21.62% |
| 3 Month Change | -27.97% |
| 1 Year Change | -46.97% |
| 3 Year Change | -74.36% |
| 5 Year Change | 69.75% |
| Change since IPO | -82.23% |
Noticias y actualizaciones recientes
ClearPoint Neuro: Macro-Induced Multiple Compression
Apr 25Are ClearPoint Neuro, Inc. (NASDAQ:CLPT) Investors Paying Above The Intrinsic Value?
Apr 19
Recent updates
ClearPoint Neuro: Macro-Induced Multiple Compression
Apr 25Are ClearPoint Neuro, Inc. (NASDAQ:CLPT) Investors Paying Above The Intrinsic Value?
Apr 19Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report
Mar 15Should You Investigate ClearPoint Neuro, Inc. (NASDAQ:CLPT) At US$6.18?
Jan 04Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?
Dec 06Is There An Opportunity With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) 41% Undervaluation?
Nov 06Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Aug 18ClearPoint Neuro, Inc. (NASDAQ:CLPT) Looks Just Right With A 40% Price Jump
Apr 17Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?
Jan 03ClearPoint Neuro: Continuous Great Execution
Sep 19ClearPoint Neuro: Picks & Shovels Galore
Aug 19ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?
Aug 18ClearPoint Neuro: A 'Picks And Shovels' Biotech Company
Jul 25ClearPoint Neuro: Continuous Execution Despite Covid Headwind
May 20Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Apr 25ClearPoint Neuro: A Strong Recovery Play Once COVID Subsides
Mar 18ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?
Jan 19ClearPoint Neuro: Underlying Growth Potential Concealed By COVID
Jan 14ClearPoint Neuro: Becoming The Neurosurgical Platform Of Choice
Oct 01ClearPoint Neuro: Path To Being The Neurological Navigation Platform Company
Aug 06Health Check: How Prudently Does ClearPoint Neuro (NASDAQ:CLPT) Use Debt?
Jul 19Clearpoint Neuro (CLPT) Investor Presentation - Slideshow
May 28Why We Think Shareholders May Be Considering Bumping Up ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) CEO Compensation
May 27US$35.00 - That's What Analysts Think ClearPoint Neuro, Inc. (NASDAQ:CLPT) Is Worth After These Results
May 13ClearPoint Neuro partners with D&K Engineering
May 10ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Path To Profitability
Apr 16Are Investors Undervaluing ClearPoint Neuro, Inc. (NASDAQ:CLPT) By 38%?
Mar 21Rentabilidad de los accionistas
| CLPT | US Medical Equipment | Mercado US | |
|---|---|---|---|
| 7D | -3.3% | 2.0% | 2.2% |
| 1Y | -47.0% | -1.4% | 22.8% |
Rentabilidad vs. Industria: CLPT obtuvo unos resultados inferiores a los del sector US Medical Equipment , que el año pasado arrojó un rendimiento del -2%.
Rentabilidad vs. Mercado: CLPT obtuvo unos resultados inferiores a los del mercado US, que fue del 24.9% el año pasado.
Volatilidad de los precios
| CLPT volatility | |
|---|---|
| CLPT Average Weekly Movement | 9.9% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: El precio de las acciones de CLPT ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de CLPT (10%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1998 | 107 | Joe Burnett | www.clearpointneuro.com |
ClearPoint Neuro, Inc. opera como empresa de dispositivos médicos principalmente en Estados Unidos. Desarrolla y comercializa plataformas para realizar procedimientos quirúrgicos mínimamente invasivos en el cerebro con intervenciones guiadas por resonancia magnética. La empresa ofrece el sistema ClearPoint, un sistema integrado para la inserción de electrodos de estimulación cerebral profunda, agujas de biopsia y catéteres láser, así como la infusión de fármacos en el cerebro.
Resumen de fundamentos de ClearPoint Neuro, Inc.
| Estadísticas fundamentales de CLPT | |
|---|---|
| Capitalización bursátil | US$142.39m |
| Beneficios(TTM) | -US$22.09m |
| Ingresos (TTM) | US$23.96m |
6.0x
Ratio precio-ventas (PS)-6.5x
Ratio precio-beneficio (PE)¿Está CLPT sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de CLPT | |
|---|---|
| Ingresos | US$23.96m |
| Coste de los ingresos | US$10.34m |
| Beneficio bruto | US$13.61m |
| Otros gastos | US$35.70m |
| Beneficios | -US$22.09m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
May 07, 2024
| Beneficios por acción (BPA) | -0.82 |
| Margen bruto | 56.83% |
| Margen de beneficio neto | -92.21% |
| Ratio deuda/patrimonio | 47.0% |
¿Cómo se ha desempeñado CLPT a largo plazo?
Ver rendimiento histórico y comparativa